Leerink Swann Starts Novartis (NVS) at Outperform; Business Diversity & MS Survey Support Positive Outlook
Tweet Send to a Friend
Leerink Swann initiates coverage on Novartis (NYSE: NVS) with a Outperform.
Leerink analyst says, "We recommend that long-term investors build ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Leerink analyst says, "We recommend that long-term investors build ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
